Farther Finance Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Buy
58,579
+1,164
+2% +$2.84K ﹤0.01% 2471
2026
Q1
$133K Buy
57,415
+48,158
+520% +$167K ﹤0.01% 2306
2025
Q4
$48K Sell
9,257
-1,971
-18% -$9.55K ﹤0.01% 2851
2025
Q3
$47.4K Buy
11,228
+1,640
+17% +$7.62K ﹤0.01% 2466
2025
Q2
$35.1K Buy
+9,588
New +$35.7K ﹤0.01% 2326
2023
Q1
Sell
-262
Closed -$705 2409
2022
Q4
$705 Buy
+262
New +$764 ﹤0.01% 1745

Other funds holding ORGO

Farther Finance Advisors's ORGO Position: Q2 2026 in Review

Farther Finance Advisors increased its Organogenesis Holdings (ORGO) stake by 2% in Q2 2026, buying an estimated $2.84K and bringing the position to 58,579 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Farther Finance Advisors first reported a position in ORGO in Q4 2022 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Farther Finance Advisors held 58,579 shares of Organogenesis Holdings worth $142K as of Q2 2026.
  • Farther Finance Advisors bought 1,164 Organogenesis Holdings shares in Q2 2026, an estimated $2.84K.
  • Organogenesis Holdings made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2471 holding.
  • Farther Finance Advisors first reported a position in Organogenesis Holdings in Q4 2022 and has held it in 6 quarters since.
  • 10 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.